"The Global Cholangiocarcinoma Alliance is a critical step towards creating a global community around cholangiocarcinoma. As a US based organization focused on cholangiocarcinoma, TargetCancer Foundation is proud to collaborate with our global partners as we work towards the common goal of supporting research, raising awareness, and ultimately identifying effective treatments for patients”

“The mission of the Global Cholangiocarcinoma Alliance (GCA) is to compassionately and masterfully improve the lives of patients and advance scientific knowledge worldwide. Proudly through collaboration, we share our passion and information to pursue early detection methods and curative treatment options in the most effective and thoughtful way”

“Translational research in cholangiocarcinoma is limited by its multilevel heterogeneity. Understanding its complex pathogenesis could help guide preventive strategies or early diagnosis in patients with clinical or subclinical underlying hepatic or biliary disease, as well as personalized medicine. The GCA will be instrumental in further understanding cholangiocarcinoma and its worldwide prevention and treatment”

“The GCA brings together a multidisciplinary approach and current worldwide expertise to raise awareness and education of a neglected and misunderstood insidious fatal disease, cholangiocarcinoma, which can be sporadic and parasite associated/induced affecting millions of people worldwide”

"The leading cause of death in most SE Asian countries is cholangiocarcinoma. The main risk factor is liver fluke infection. Unfortunately, it has been an overlooked disease. The launch of the GCA has changed that, bringing it to the attention of the world. I am proud to be part of this important work"

“The Global Cholangiocarcinoma Alliance will empower all of us who are united by the vision of a better future for everyone affected by cholangiocarcinoma, enabling us to work with a collective voice worldwide for raised awareness and more international research towards improved treatments and, ultimately, a cure. AMMF is proud to work with the Alliance towards this goal”

“Cholangiocarcinoma is a global problem that we can only hope to solve with a global solution. The GCA addresses the urgent need for the international community to come together and collaborate from bench to bedside. Advocacy in partnership with scientific, medical, industry & regulatory bodies will make a difference in the scope and impact of what we would be able to accomplish individually for CCA patients across the world. The Cholangiocarcinoma Foundation is pleased to join hands with our partners around the world in this important effort to improve access and treatment options for all CCA patients”

“Raising awareness of cholangiocarcinoma is incredibly important since this relatively rare malignancy in the bile ducts is increasing in both incidence and mortality rates worldwide. Patients diagnosed with this dismal disease have benefitted marginally from clinical and scientific achievements in oncology over the past 30 years. Thus, the Global Cholangiocarcinoma Alliance (GCA) initiative is essential to emphasize education, international collaborations and raising a public voice for the silent patient”